Role of Omega-3 Fatty Acids in Modulating Retinal Microvascular Changes in Type 1 Diabetes

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of this clinical trial is to learn if omega-3 fatty acid supplements help maintain healthy blood vessels in the eyes of adults with type 1 diabetes. It will also learn about the safety of omega-3 supplements. The main questions it aims to answer are: Do omega-3 supplements improve the health of retinal blood vessels in adults with type 1 diabetes? Are there any side effects when taking omega-3 supplements? Researchers will compare participants taking omega-3 supplements to a control group (if applicable) to see if the supplements help support retinal blood vessel health. Participants will: Take a daily omega-3 supplement for the duration of the study Attend regular eye exams to monitor changes in the retina Report any side effects or health changes during the study

Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Maximum Age: 45
Healthy Volunteers: f
View:

• Diagnosis of Type 1 Diabetes Age between 10 and 45 years Duration of diabetes ≥ 2 years Mild to moderate diabetic retinopathy allowed (based on fundus examination)

Locations
Other Locations
Pakistan
Children Hospital Lahore and Ali Fatima Hospital
RECRUITING
Lahore
Contact Information
Primary
Nida Amin, PhD(Scholar) Optometry
nidaa4644@gmail.com
+923207344644
Time Frame
Start Date: 2025-10-01
Estimated Completion Date: 2026-07-30
Participants
Target number of participants: 80
Treatments
Experimental: Omega-3 Supplement Group
Participants will take one daily capsule containing 1000 mg of combined EPA and DHA. The supplement is taken orally with food. Eye exams will be performed every three months to monitor retinal blood vessel health.
Placebo_comparator: Omega-3 Control Group
Participants will take a daily capsule that looks identical to the omega-3 supplement but contains no active omega-3 fatty acids. Eye exams will be performed every three months to monitor retinal blood vessel health. Participants will report any health changes.
Sponsors
Leads: University of Faisalabad

This content was sourced from clinicaltrials.gov